Atticus Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $686K | Sell |
3,698
-42
| -1% | -$7.8K | 0.19% | 69 |
|
|
2025
Q1 | $784K | Sell |
3,740
-37
| -1% | -$7.75K | 0.26% | 54 |
|
|
2024
Q4 | $671K | Buy |
3,777
+3
| +0.1% | +$533 | 0.21% | 61 |
|
|
2024
Q3 | $745K | Buy |
3,774
+60
| +2% | +$11.8K | 0.24% | 52 |
|
|
2024
Q2 | $637K | Sell |
3,714
-274
| -7% | -$47K | 0.21% | 56 |
|
|
2024
Q1 | $726K | Sell |
3,988
-238
| -6% | -$43.3K | 0.24% | 52 |
|
|
2023
Q4 | $655K | Sell |
4,226
-1,011
| -19% | -$157K | 0.23% | 55 |
|
|
2023
Q3 | $781K | Buy |
5,237
+6
| +0.1% | +$894 | 0.3% | 48 |
|
|
2023
Q2 | $705K | Buy |
5,231
+5
| +0.1% | +$674 | 0.26% | 57 |
|
|
2023
Q1 | $833K | Buy |
5,226
+55
| +1% | +$8.77K | 0.32% | 48 |
|
|
2022
Q4 | $836K | Sell |
5,171
-52
| -1% | -$8.4K | 0.34% | 52 |
|
|
2022
Q3 | $800K | Hold |
5,223
| – | – | 0.39% | 40 |
|
|
2022
Q2 | $800K | Buy |
5,223
+560
| +12% | +$85.8K | 0.33% | 52 |
|
|
2022
Q1 | $756K | Buy |
4,663
+1,612
| +53% | +$261K | 0.28% | 59 |
|
|
2021
Q4 | $413K | Sell |
3,051
-617
| -17% | -$83.5K | 0.16% | 86 |
|
|
2021
Q3 | $396K | Buy |
3,668
+8
| +0.2% | +$864 | 0.17% | 69 |
|
|
2021
Q2 | $412K | Buy |
3,660
+284
| +8% | +$32K | 0.18% | 75 |
|
|
2021
Q1 | $365K | Buy |
3,376
+2
| +0.1% | +$216 | 0.17% | 78 |
|
|
2020
Q4 | $362K | Buy |
3,374
+405
| +14% | +$43.5K | 0.18% | 70 |
|
|
2020
Q3 | $260K | Buy |
2,969
+314
| +12% | +$27.5K | 0.16% | 75 |
|
|
2020
Q2 | $261K | Sell |
2,655
-524
| -16% | -$51.5K | 0.17% | 76 |
|
|
2020
Q1 | $242K | Buy |
3,179
+9
| +0.3% | +$685 | 0.2% | 69 |
|
|
2019
Q4 | $281K | Buy |
+3,170
| New | +$281K | 0.18% | 70 |
|